Learn about a nonhormonal FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause
Tuesday, May 20, 2025
11:45 AM – 12:45 PM
In this session, we will review an FDA-approved treatment for moderate to severe vasomotor symptoms due to menopause, including indication, mechanism of action, and clinical safety and efficacy.